Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Global guidelines generally recommend GLP-1 or GIP/GLP-1 injections for: BMI 30 kg/m , or BMI 27 kg/m with at least one weight-related condition , such as: Type 2 diabetes High blood pressure High cholesterol Sleep apnea Fatty liver disease Not suitable for: Pregnant or breastfeeding individuals Anyone with a history of pancreatitis Patients with certain endocrine or thyroid cancers Children/adolescents (unless specifically approved) In Singapore, eligibility is assessed by a licensed doctor based on BMI, metabolic health, and previous response to lifestyle interventions
No batch-specific CoA PDF is published on the public product page as of 2026, so treat any stated percentage as supplier-declared until you receive a chromatogram on request
Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the step 1, 2, and 3 trials
It is the most studied fiber supplement in the context of gastrointestinal management, and its properties align almost perfectly with what GLP-1 users need
Yes, inflammation leads to weight gain
US$ 26.33
US$ 21.67
US$ 25.25
US$ 24.93
US$ 27.72
US$ 23.05
US$ 24.88
US$ 28.78
